NEW YORK (GenomeWeb) – Affymetrix today announced that it has signed a deal to collaborate with MTI subsidiary EverGene on a personal genomics service for the Japanese market.
Under the deal, Affymetrix's Axiom genotyping platform will be used with EverGene's DearGene Starter Kit, a consumer genotyping service that provides information about an individual's risk for disease. Samples for the kit are processed exclusively by Takara Bio, according to a joint statement released by Affy and EverGene.
Financial terms of the supply agreement were not disclosed.